Croda International Appoints Jill Anderson as Non-Executive Director
Key highlights
- Jill Anderson joins Croda's Board on 12 January 2026.
- She will be part of the Audit, Nomination, and Remuneration Committees.
- Jill has over 30 years of experience in healthcare leadership.
- She was GSK's R&D CFO until 2024.
Appointment Announcement
On 8 January 2026, Croda International Plc announced the appointment of Jill Anderson as a Non-Executive Director. She will officially join the Board on 12 January 2026 and will serve on the Audit, Nomination, and Remuneration Committees.
Professional Background
Jill Anderson brings over 30 years of experience in international leadership roles within the healthcare industry. Her expertise spans finance, commercial research, and supply chain functions. Most recently, she served as the Chief Financial Officer of GSK's R&D division until her retirement in 2024.
Current Roles
In addition to her new role at Croda, Jill Anderson is currently a Non-Executive Director and Audit Committee Chair at Spire Healthcare Group plc.
Source: Croda